Torthaí cuardaigh - Guido J.R. Zaman
- 1 - 15 toradh as 15 á dtaispeáint
-
1
Ligand-induced folding of the guanine-sensing riboswitch is controlled by a combined predetermined–induced fit mechanism de réir Otmar M. Ottink, S.M. Rampersad, Marco Tessari, Guido J.R. Zaman, Hans A. Heus, Sybren S. Wijmenga
Foilsithe / Cruthaithe 2007Artigo -
2
-
3
Membrane Topology and Glycosylation of the Human Multidrug Resistance-associated Protein de réir Éva Bakos, Tamás Hegedűs, Zsolt Holló, Ervin Welker, Gábor Tusnády, Guido J.R. Zaman, Marcel J. Flens, András Váradi, Balázs Sarkadi
Foilsithe / Cruthaithe 1996Artigo -
4
Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158 de réir Yvonne Grobben, Joost C.M. Uitdehaag, Nicole Willemsen‐Seegers, Werner W.A. Tabak, Jos de Man, Rogier C. Buijsman, Guido J.R. Zaman
Foilsithe / Cruthaithe 2019Artigo -
5
Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. de réir Guido J.R. Zaman, J. Lankelma, Olaf van Tellingen, Jos H. Beijnen, Henk Dekker, Coen C. Paulusma, Ronald P.J. Oude Elferink, Frank Baas, Piet Borst
Foilsithe / Cruthaithe 1995Artigo -
6
Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability de réir Cristina Viganó, Conrad von Schubert, Erik Ahrné, Alexander Schmidt, Thomas Lorber, Lukas Bubendorf, Judith R.F. de Vetter, Guido J.R. Zaman, Zuzana Štorchová, Erich A. Nigg
Foilsithe / Cruthaithe 2018Artigo -
7
TTK Inhibitors as a Targeted Therapy for<i>CTNNB1</i>(<b>β</b>-catenin) Mutant Cancers de réir Guido J.R. Zaman, Jeroen A.D.M. de Roos, Marion A.A. Libouban, Martine B.W. Prinsen, Jos de Man, Rogier C. Buijsman, Joost C.M. Uitdehaag
Foilsithe / Cruthaithe 2017Artigo -
8
Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. de réir Raymond Evers, Guido J.R. Zaman, Liesbeth van Deemter, H W Jansen, Jero Calafat, Lauran C. J. M. Oomen, Ronald P.J. Oude Elferink, Piet Borst, Alfred H. Schinkel
Foilsithe / Cruthaithe 1996Artigo -
9
Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors de réir Neil T. Conlon, Jeffrey J. Kooijman, Suzanne J.C. van Gerwen, Winfried R. Mulder, Guido J.R. Zaman, Irmina Diala, Lisa D. Eli, Alshad S. Lalani, John Crown, Denis M. Collins
Foilsithe / Cruthaithe 2021Artigo -
10
Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells de réir Anastasia Y Kuznetsova, Katarzyna Seget, Giuliana K Moeller, Mirjam S. de Pagter, Jeroen A.D.M. de Roos, Milena Dürrbaum, Christian Kuffer, Stefan Müller, Guido J.R. Zaman, Wigard P. Kloosterman, Zuzana Štorchová
Foilsithe / Cruthaithe 2015Artigo -
11
β-Arrestin Recruitment and G Protein Signaling by the Atypical Human Chemokine Decoy Receptor CCX-CKR de réir Anne O. Watts, Folkert Verkaar, Miranda M.C. van der Lee, Claudia A.W. Timmerman, Martien Kuijer, Jody van Offenbeek, Lambertus H.C.J. van Lith, Martine J. Smit, Rob Leurs, Guido J.R. Zaman, Henry F. Vischer
Foilsithe / Cruthaithe 2013Artigo -
12
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia de réir Kirsten Canté-Barrett, J A P Spijkers-Hagelstein, Jessica G. C. A. M. Buijs-Gladdines, Joost C.M. Uitdehaag, Willem K. Smits, Jordy Van Der Zwet, Rogier C. Buijsman, Guido J.R. Zaman, Rob Pieters, Jules P.P. Meijerink
Foilsithe / Cruthaithe 2016Artigo -
13
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study de réir Yunlei Li, Jessica G. C. A. M. Buijs-Gladdines, Kirsten Canté-Barrett, Andrew Stubbs, Eric Vroegindeweij, Willem K. Smits, Ronald van Marion, Winand N.M. Dinjens, Martin A. Horstmann, Roland P. Kuiper, Rogier C. Buijsman, Guido J.R. Zaman, Peter J. van der Spek, Rob Pieters, Jules P.P. Meijerink
Foilsithe / Cruthaithe 2016Artigo -
14
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model de réir Ana Maia, J. de Man, Ute Boon, Aniek Janssen, Ji‐Ying Song, Manja Omerzu, Jan Gerard Sterrenburg, Martine B.W. Prinsen, Nicole Willemsen‐Seegers, J.A.D.M. De Roos, Antoon M. van Doornmalen, Joost C.M. Uitdehaag, Geert J.P.L. Kops, Jos Jonkers, Rogier C. Buijsman, Guido J.R. Zaman, René H. Medema
Foilsithe / Cruthaithe 2015Artigo -
15
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines de réir Gisele Nishiguchi, Lauren G. Mascibroda, Sarah M. Young, Elizabeth A. Caine, Sherif Abdelhamed, Jeffrey J. Kooijman, Darcie J. Miller, Sourav Das, Kevin M. McGowan, Anand Mayasundari, Zhe Shi, Juan M. Barajas, Ryan Hiltenbrand, Anup Aggarwal, Yunchao Chang, Vibhor Mishra, Shilpa Narina, Melvin E. Thomas, Allister J. Loughran, Ravi C. Kalathur, Kaiwen Yu, Suiping Zhou, Xusheng Wang, Anthony A. High, Junmin Peng, Shondra M. Pruett‐Miller, Danette L. Daniels, Marjeta Urh, Anang A. Shelat, Charles G. Mullighan, Kristin M. Riching, Guido J.R. Zaman, Marcus Fischer, Jeffery M. Klco, Zoran Ranković
Foilsithe / Cruthaithe 2024Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Gene
Genetics
Biochemistry
Cancer research
Cell biology
Cancer
Chemistry
Enzyme
Cell culture
Molecular biology
Cell
Computational biology
Immunology
Leukemia
Medicine
Oncology
Receptor
Signal transduction
Aneuploidy
Antibiotics
Bioinformatics
Biophysics
Breast cancer
Cancer cell
Chromosome
Chromosome instability
Daunorubicin
Glutathione
Internal medicine